The New Jersey Innovation Institute (NJII), an NJIT Corporation, and Merck have been awarded a Biopharmaceutical Workforce Training Acceleration Project by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute designed to advance biopharmaceutical manufacturing in the U.S.
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of diseases by addressing disease targets expressed in the eye and central nervous system (CNS), in addition to a select number of targets expressed in the liver.
MilliporeSigma recently announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next- generation bioprocessing. MilliporeSigma’s Pellicon Capsule with Ultracel Membrane has been recognized for Best New Product.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that it has invested a further $5M at the company’s Somerset, New Jersey, drug development center of excellence to expand its OptiMelt hot melt extrusion (HME) capabilities.
Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has strengthened its leadership team with the appointment of Kevin Orfan as president of Sharp Packaging US.
MilliporeSigma recently unveiled its BioContinuum Buffer Delivery Platform, a new building block in the BioContinuum Platform for next-generation bioprocessing, at INTERPHEX in New York City. The BioContinuum Buffer Delivery Platform is part of MilliporeSigma’s BioContinuum Platform to deliver “contiGuous” bioprocessing.
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) and Automated Systems of Tacoma, LLC (AST), a leading provider of flexible aseptic filling systems, announce their partnership on the new GENiSYS R filling machine for syringes, cartridges and vials. Pii has purchased a GENiSYS R system, capable of automated cGMP aseptic small batch processing, and will collaborate with AST on its installation at its Hunt Valley, MD location.
The International Society for Pharmaceutical Engineering (ISPE) recently announced the 2019 Facility of the Year Awards (FOYA) Category Winners at its 2019 Europe Annual Conference in Dublin, Ireland.
UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US.
|
|
|
|
|
|
|
|
|